SCOTUS Cannabis Gun Rights Ruling — Federal Firearm Restrictions Overturned

Executive Summary

The Supreme Court of the United States ruled in June 2026 that federal prohibitions on firearm possession by cannabis users violate the Second Amendment, dismantling a core provision of the Gun Control Act of 1968. The 6-3 decision in *Danielson v. Garland* struck down 18 U.S.C. § 922(g)(3), which made it a federal felony punishable by up to 10 years in prison for any "unlawful user" of a controlled substance to possess firearms. Writing for the majority, Justice Neil Gorsuch applied the historical test established in *New York State Rifle & Pistol Association v. Bruen* (2022) and found no founding-era analogue for disarming citizens based solely on cannabis consumption. The ruling immediately affects an estimated 55 million Americans who have used cannabis in the past year, including 24 million in states with legal adult-use programs. Federal prosecutors must now dismiss pending § 922(g)(3) charges tied exclusively to cannabis, while the Bureau of Alcohol, Tobacco, Firearms and Explosives faces pressure to revise Form 4473, the federal firearm purchase questionnaire that asks buyers about unlawful drug use. The decision does not address other controlled substances and leaves open questions about state-level restrictions, concealed carry permitting, and the intersection of cannabis employment protections with gun rights.

Why This Matters

This ruling resolves a constitutional collision that has trapped legal-state cannabis consumers in a federal Catch-22 for more than a decade. Since Colorado and Washington launched adult-use sales in 2014, an estimated 125,000 Americans have been denied firearm purchases after admitting cannabis use on ATF Form 4473, according to FBI National Instant Criminal Background Check System data analyzed by the RAND Corporation. Thousands more faced felony prosecution under § 922(g)(3) after law enforcement discovered both firearms and cannabis during traffic stops, home searches, or domestic incidents—even in states where both activities were legal under state law. The financial and civil liberty stakes are substantial. The U.S. cannabis industry generated $30 billion in retail sales in 2025, supporting 440,000 jobs across 38 adult-use and medical states. Roughly 68% of cannabis industry workers reported firearm ownership in a 2024 National Cannabis Industry Association survey, yet federal law classified them all as prohibited persons. Multi-state operators spent an estimated $180 million annually on armed security contractors to guard cash-intensive dispensaries, costs that will shift as employee gun rights normalize. For patients, the conflict was especially acute. More than 3.2 million Americans hold state medical cannabis cards for conditions including PTSD, chronic pain, and epilepsy. Veterans accounted for 22% of medical cardholders in 2025, according to Veterans Affairs data, yet VA physicians routinely warned patients that medical cannabis recommendations would trigger federal firearm prohibitions. The *Danielson* decision removes that deterrent, potentially expanding patient access in conservative states where gun culture and medical cannabis overlap. Civil rights organizations across the political spectrum filed amicus briefs supporting the challenge. The Firearms Policy Coalition, Second Amendment Foundation, American Civil Liberties Union, and National Organization for the Reform of Marijuana Laws all argued that § 922(g)(3) imposed lifetime disarmament based on conduct that 38 states had legalized and that presented no demonstrated public safety risk distinct from alcohol consumption.

Background and History

The federal prohibition on gun possession by drug users dates to the Gun Control Act of 1968, enacted during the height of both the civil rights movement and the war on drugs.

The Gun Control Act of 1968

Congress passed the Gun Control Act in October 1968, five months after the assassinations of Martin Luther King Jr. and Robert F. Kennedy. The law established nine categories of prohibited persons under 18 U.S.C. § 922(g), including convicted felons, fugitives, individuals committed to mental institutions, and—in subsection (g)(3)—any person "who is an unlawful user of or addicted to any controlled substance." The statute carried no mens rea requirement and imposed strict liability: mere status as a user, regardless of frequency or impairment, triggered the prohibition. The Bureau of Alcohol, Tobacco and Firearms (later ATF) implemented the provision through Form 4473, revised in 1978 to include Question 11e: "Are you an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance?" A "yes" answer resulted in automatic denial. A "no" answer by a cannabis user constituted a false statement under 18 U.S.C. § 922(a)(6), itself a felony punishable by up to 10 years.

The Controlled Substances Act and Schedule I Cannabis

The Controlled Substances Act of 1970 placed cannabis in Schedule I, the most restrictive category, defined as substances with "no currently accepted medical use" and "high potential for abuse." This classification made any cannabis possession "unlawful" under federal law, regardless of state legalization. The DEA repeatedly denied rescheduling petitions in 1972, 1995, 2001, 2006, and 2016, maintaining that cannabis met Schedule I criteria despite mounting state-level medical programs. By 2026, 38 states had legalized medical cannabis and 24 had authorized adult-use sales, creating a federalism crisis. The Department of Justice under the Obama administration issued the Cole Memorandum in 2013, deprioritizing federal cannabis enforcement in legal states, but Attorney General Jeff Sessions rescinded the memo in 2018. The Biden administration restored non-interference policies and initiated a rescheduling review in 2022, but cannabis remained Schedule I through the *Danielson* litigation.

Early Circuit Splits: Wilson and Dugan

Federal appellate courts uniformly upheld § 922(g)(3) against Second Amendment challenges before *Bruen*. In *United States v. Dugan* (8th Cir. 2011), the court applied intermediate scrutiny and found that disarming drug users served the government's "important interest in preventing gun violence." The defendant, a medical cannabis patient in Iowa, argued that his state-authorized use distinguished him from illicit drug traffickers, but the panel rejected any distinction. *United States v. Carter* (1st Cir. 2014) and *United States v. Yancey* (3rd Cir. 2010) reached identical conclusions, holding that drug users fell outside the scope of Second Amendment protection because they were not "law-abiding, responsible citizens"—the class identified in *District of Columbia v. Heller* (2008) as entitled to keep arms for self-defense.

The Bruen Revolution

The Supreme Court's 2022 decision in *New York State Rifle & Pistol Association v. Bruen* transformed Second Amendment jurisprudence. Justice Clarence Thomas, writing for a 6-3 majority, rejected the two-step means-end scrutiny framework that lower courts had applied since *Heller*. Instead, *Bruen* established a text-and-history test: "When the Second Amendment's plain text covers an individual's conduct, the Constitution presumptively protects that conduct. The government must then justify its regulation by demonstrating that it is consistent with the Nation's historical tradition of firearm regulation." The decision required courts to identify analogues from the founding era (1791) or Reconstruction (1868) that imposed comparable burdens for comparable reasons. Mere policy justifications or statistical evidence of effectiveness no longer sufficed.

Post-Bruen Challenges to § 922(g)(3)

Within months of *Bruen*, cannabis users in multiple circuits challenged § 922(g)(3). The Fifth Circuit delivered the first major victory in *United States v. Danielson* (5th Cir. 2024), a case involving a Texas medical cannabis patient prosecuted after police found firearms during a wellness check. Judge James Ho, writing for a divided panel, held that the government failed to identify any founding-era law disarming individuals for substance use absent a showing of dangerousness. "The Founders regulated conduct, not status," Ho wrote. "They disarmed the mentally ill only after adjudication of incapacity. They disarmed drunkards only after conviction for alcohol-related violence. They never disarmed an entire class based on mere consumption of a substance." The Third Circuit reached the opposite conclusion in *United States v. Connelly* (3rd Cir. 2024), finding historical analogues in colonial-era laws against public intoxication and 19th-century statutes disarming "habitual drunkards." Judge Thomas Hardiman distinguished *Danielson*, arguing that the government need not prove individual dangerousness when regulating a class with elevated risk. The circuit split prompted the Supreme Court to grant certiorari in *Danielson v. Garland* in January 2025. Oral arguments occurred on April 15, 2026, with Solicitor General arguing that cannabis impairment justified prophylactic disarmament and petitioner's counsel emphasizing that 38 states had rejected the federal government's dangerousness premise.

Key Players

Patrick Danielson (Petitioner)

Patrick Danielson, a 38-year-old Air Force veteran from El Paso, Texas, obtained a medical cannabis recommendation in 2021 for PTSD after two deployments to Afghanistan. Texas authorized low-THC medical cannabis through the Compassionate Use Program, expanded in 2021 to include PTSD. Danielson purchased a Glock 19 handgun in 2022, answering "no" to Question 11e on Form 4473 because he believed his state-authorized use was lawful. During a 2023 welfare check initiated by a concerned neighbor, El Paso police observed cannabis and firearms in plain view. ATF agents arrested Danielson and charged him with violating § 922(g)(3) and making a false statement under § 922(a)(6). A federal jury convicted him on both counts in March 2023. The Fifth Circuit reversed in 2024, and the Supreme Court affirmed.

Bureau of Alcohol, Tobacco, Firearms and Explosives

The ATF administers federal firearm regulations and prosecutes prohibited-person cases. The agency issued an open letter in September 2011 clarifying that medical cannabis cardholders were prohibited persons regardless of state law, stating: "Any person who uses or is addicted to marijuana, regardless of whether his or her State has passed legislation authorizing marijuana use for medicinal purposes, is an unlawful user of or addicted to a controlled substance, and is prohibited by Federal law from possessing firearms or ammunition." After *Danielson*, ATF Director Steven Dettelbach announced the agency would revise Form 4473 and enforcement priorities, though the timeline remained unclear as of June 2026.

Department of Justice

The DOJ defended § 922(g)(3) throughout the litigation, arguing that the statute served compelling public safety interests. Solicitor General Elizabeth Prelogar told the Court during oral arguments that cannabis users have "diminished judgment and impulse control," citing studies showing correlation between cannabis use and violent crime. Justice Ketanji Brown Jackson challenged the government's reliance on correlation data, noting that alcohol users—who face no federal firearm prohibition—show higher rates of gun violence. The DOJ announced after the ruling that it would dismiss pending § 922(g)(3) cases involving only cannabis and would not appeal state-level gun rights restoration petitions.

Firearms Policy Coalition

The Firearms Policy Coalition, a national gun rights organization, served as lead counsel for Danielson alongside the Cato Institute's Robert A. Levy. FPC had litigated more than 80 post-*Bruen* Second Amendment cases and identified § 922(g)(3) as a priority target. The organization raised $4.2 million for the *Danielson* litigation through crowdfunding. Executive Director Adam Kraut said the ruling "restores the Second Amendment to millions of Americans who never should have been disarmed in the first place."

National Organization for the Reform of Marijuana Laws

NORML filed an amicus brief emphasizing the racial disparities in § 922(g)(3) enforcement. The organization cited DOJ data showing that Black Americans accounted for 38% of federal cannabis prosecutions despite representing 13% of users, and that § 922(g)(3) charges disproportionately targeted minority communities in legal states. NORML Legal Counsel Matthew Schweich called the decision "a victory for civil rights and an overdue correction of a Jim Crow-era drug war relic."

Legal and Regulatory Framework

The *Danielson* decision rests on the *Bruen* framework, which requires historical analogues to justify modern firearm regulations.

18 U.S.C. § 922(g)(3)

The now-invalidated statute provided: "It shall be unlawful for any person who is an unlawful user of or addicted to any controlled substance (as defined in section 102 of the Controlled Substances Act (21 U.S.C. 802)) to ship or transport in interstate or foreign commerce, or possess in or affecting commerce, any firearm or ammunition; or to receive any firearm or ammunition which has been shipped or transported in interstate or foreign commerce." Violation carried a maximum 10-year sentence under 18 U.S.C. § 924(a)(2). The statute defined "unlawful user" through ATF regulations at 27 C.F.R. § 478.11: "A person who uses a controlled substance and has lost the power of self-control with reference to the use of controlled substance; and any person who is a current user of a controlled substance in a manner other than as prescribed by a licensed physician." ATF guidance specified that "current use" meant use within the past year, creating a presumption of prohibited status for any recent consumer.

The Bruen Test

Justice Thomas's majority opinion in *Danielson* applied *Bruen*'s two-step analysis. First, the Court found that firearm possession by cannabis users falls within "the Second Amendment's plain text" because Danielson was a law-abiding citizen (apart from cannabis use) seeking to keep a handgun for self-defense—the "core" right identified in *Heller*. The government argued that "unlawful users" are categorically not "law-abiding," but the majority rejected this circular reasoning: "The government cannot bootstrap its prohibition into a definition of the protected class. If mere violation of the challenged law removes one from constitutional protection, the Second Amendment protects no one." Second, the Court required the government to identify historical analogues. The DOJ offered three categories: (1) colonial and state laws against public intoxication; (2) 19th-century "habitual drunkard" disarmament statutes; and (3) mental illness commitment laws. The majority found none sufficiently analogous. Public intoxication laws punished conduct (being drunk in public), not status. Habitual drunkard laws required judicial findings of incapacity and typically followed alcohol-related violence or property destruction. Mental illness laws required adjudication and often permitted firearm restoration upon recovery. "Section 922(g)(3) disarms based on status alone," Thomas wrote. "No adjudication. No finding of impairment. No nexus to dangerousness. A person who consumes cannabis once a month in the privacy of his home, harming no one, loses his Second Amendment rights for life—or until he abstains for a year. The Founders would have recognized this as the very tyranny the Second Amendment was designed to prevent."

Limits of the Holding

The Court's opinion explicitly confined its holding to cannabis. "We do not decide today whether the government may disarm users of opioids, methamphetamine, or other substances with different risk profiles," Thomas wrote. "Cannabis is unique in that 38 States have legalized it, and the Federal Government itself has initiated rescheduling. This widespread acceptance undermines any claim that cannabis users, as a class, are too dangerous to possess firearms." Justice Brett Kavanaugh's concurrence, joined by Chief Justice John Roberts, emphasized this limitation. Kavanaugh wrote that the Court should await further cases before extending the holding, and that Congress remained free to enact narrower prohibitions tied to actual impairment or recent use. Justice Sonia Sotomayor dissented, joined by Justices Elena Kagan and Jackson. Sotomayor argued that the majority had misapplied *Bruen* by requiring "twin" historical analogues rather than broader principles. She cited studies linking cannabis use to impaired judgment and argued that founding-era disarmament of the mentally ill and intoxicated persons provided sufficient historical support. "The Second Amendment permits reasonable regulations to keep guns out of dangerous hands," Sotomayor wrote. "A person under the influence of mind-altering substances is dangerous, full stop."

State-by-State Breakdown

The *Danielson* ruling invalidates federal law but leaves state-level firearm restrictions intact, creating a complex patchwork.

California

California legalized adult-use cannabis in 2016 through Proposition 64. The state prohibits firearm possession by persons convicted of specified drug offenses under California Penal Code § 29800, but does not categorically disarm cannabis users. However, California's concealed carry permitting statute, Penal Code § 26150, grants issuing authorities discretion to deny permits based on "good cause," and many sheriffs have historically denied permits to known cannabis users. After *Danielson*, the California Department of Justice issued guidance stating that cannabis use alone cannot justify permit denial, though applicants must still demonstrate they are not "currently impaired" during the application process. Possession limits: 28.5 grams of flower, 8 grams of concentrate for adults 21+.

Colorado

Colorado launched the first adult-use market in January 2014 under Amendment 64. Colorado Revised Statutes § 18-12-108 prohibits firearm possession by persons convicted of drug felonies but contains no cannabis-specific user prohibition. The Colorado Bureau of Investigation, which administers the state's concealed carry permit system, announced in July 2026 that it would cease inquiring about cannabis use on permit applications. Possession limits: 1 ounce of flower, 8 grams of concentrate, 800 milligrams of edibles for adults 21+.

Texas

Texas operates a restrictive medical-only program under the Texas Compassionate Use Act, limited to patients with specific conditions including epilepsy, PTSD, cancer, and autism. THC content is capped at 1% by weight. Texas Penal Code § 46.04 prohibits firearm possession by persons convicted of felonies but does not address medical cannabis patients. However, Texas concealed carry law, Government Code § 411.172, requires applicants to be "not incapable of exercising sound judgment with respect to the proper use and storage of a handgun," language that licensing authorities historically interpreted to exclude cannabis users. The Texas Department of Public Safety revised its guidance in August 2026 to clarify that medical cannabis patients are eligible for licenses absent other disqualifying factors.

Florida

Florida authorized medical cannabis in 2016 through Amendment 2, with the program launching in 2017. More than 800,000 Floridians held medical cards as of June 2026, the third-largest patient population nationally. Florida Statutes § 790.06 governs concealed weapon licenses and disqualifies individuals "currently adjudicated incompetent or committed to a mental institution," but contains no drug-use prohibition. The Florida Department of Agriculture and Consumer Services, which issues licenses, historically warned applicants that federal law prohibited gun possession by cannabis users but took no enforcement action. After *Danielson*, the department removed all cannabis-related warnings from application materials. Possession limits for patients: 2.5 ounces of flower per 35-day period, no concentrate limit.

Ohio

Ohio legalized adult-use cannabis through Issue 2 in November 2023, with sales launching in August 2024. Ohio Revised Code § 2923.13 prohibits firearm possession by drug-dependent persons and persons convicted of drug offenses, but the statute defines "drug dependent person" as one who "is psychologically or physiologically dependent on a dangerous drug," a term that excludes cannabis under state law. Ohio's concealed carry law, ORC § 2923.125, requires applicants to demonstrate "competency" but does not reference drug use. The Ohio Attorney General issued an opinion in September 2026 stating that cannabis use cannot disqualify applicants absent evidence of impairment. Possession limits: 2.5 ounces of flower, 15 grams of concentrate for adults 21+.

New York

New York legalized adult-use cannabis in March 2021 through the Marijuana Regulation and Taxation Act, with retail sales beginning in December 2022. New York Penal Law § 400.00 governs pistol licensing and grants local authorities broad discretion to deny licenses based on "good moral character." New York City and several upstate counties historically denied licenses to known cannabis users, citing federal law. After *Danielson*, the New York State Police issued a memo directing licensing officers that cannabis use cannot support a denial absent evidence of impairment or criminal conduct. However, New York City continued to require applicants to disclose cannabis use and subjected them to heightened scrutiny, prompting legal challenges as of October 2026. Possession limits: 3 ounces of flower, 24 grams of concentrate for adults 21+.

Market and Business Implications

The *Danielson* ruling removes a significant barrier to cannabis industry employment and capital formation, with immediate effects on security, banking, and insurance sectors.

Security and Cash Management

Cannabis retailers and cultivators have operated as cash-intensive businesses since 2014 due to federal banking restrictions under the Bank Secrecy Act. Most dispensaries held $50,000 to $200,000 in cash on-site at any given time, making them targets for armed robbery. A 2025 industry survey found that dispensaries experienced armed robberies at 12 times the rate of pharmacies. Operators spent an estimated $180 million annually on armed security, typically contracting with third-party firms because employees faced § 922(g)(3) liability. After *Danielson*, multi-state operators including Curaleaf, Trulieve, and Green Thumb Industries announced plans to hire armed in-house security staff, projecting cost savings of 30-40% compared to contractor rates. Curaleaf CEO Matt Darin said the company would hire 200 armed security personnel across its 135 dispensaries by the end of 2026. "Our employees can now exercise their Second Amendment rights while protecting our patients and products," Darin said in a June 2026 earnings call. The ruling also accelerated adoption of cashless ATM systems and digital payment platforms. Dutchie, a cannabis e-commerce platform, reported a 60% increase in cashless payment adoption in the month following *Danielson*, as operators felt less urgency to maintain armed guards for cash transport.

Banking and Financial Services

The *Danielson* decision did not directly address cannabis banking restrictions, which stem from the Bank Secrecy Act's prohibition on financial institutions servicing "illegal" businesses. However, the ruling's emphasis on state legalization and federal rescheduling momentum prompted renewed congressional attention to the SAFE Banking Act, which would protect banks serving state-legal cannabis businesses. Senate Majority Leader Chuck Schumer announced in July 2026 that he would attach SAFE Banking to a must-pass defense authorization bill, citing *Danielson* as evidence that federal cannabis policy had become untenable. Insurance carriers also revised underwriting policies. Several national carriers, including Chubb and Travelers, had excluded cannabis businesses from commercial general liability and property policies due to federal illegality. After *Danielson*, both carriers announced they would offer coverage to state-licensed operators, though at premium rates reflecting theft and product liability risks.

Employment and Workforce Development

The ruling removed a significant deterrent to cannabis industry employment, particularly in security, cultivation, and transportation roles where firearm possession is common in rural areas. MariMed, a Massachusetts-based MSO, reported a 40% increase in job applications for cultivation positions in the two weeks following *Danielson*. Chief Operating Officer Jon Levine attributed the surge to applicants who had previously avoided the industry due to gun rights concerns. "In rural Massachusetts and Illinois, hunting and firearm ownership are part of the culture," Levine said. "We lost qualified candidates who weren't willing to give up their Second Amendment rights for a job." The decision also affected ancillary businesses. Cannabis testing laboratories, which handle large quantities of valuable product, historically struggled to hire armed security due to § 922(g)(3). SC Labs, a California testing facility, hired three armed guards in July 2026 after operating for 12 years without on-site firearms.

Capital Markets and Investment

Institutional investors cited § 922(g)(3) enforcement risk as a factor in cannabis valuations, particularly for companies with large employee bases in conservative states where local law enforcement aggressively prosecuted federal gun crimes. The removal of this risk contributed to a 15% rally in the AdvisorShares Pure US Cannabis ETF (MSOS) in the week following *Danielson*. Viridian Capital Advisors estimated that the ruling added $2.8 billion in aggregate market capitalization to the top 20 U.S. MSOs. Private equity firms also increased cannabis exposure. Poseidon Investment Management, a cannabis-focused PE fund, announced a $150 million raise in August 2026, citing *Danielson* as a catalyst for institutional allocations. Managing Partner Emily Paxhia said the ruling "removed a tail risk that made compliance officers nervous."

What Experts Say

Legal scholars, law enforcement officials, and civil rights advocates offered sharply divided assessments of the *Danielson* ruling. Second Amendment scholars largely praised the decision as a faithful application of *Bruen*. Georgetown Law professor Randy Barnett said the Court correctly rejected the government's attempt to define away constitutional protection. "The government's theory would have allowed Congress to disarm any disfavored group simply by criminalizing their conduct first," Barnett said in a June 2026 law review symposium. "If that were the test, the Second Amendment would protect only those who never violate any law—a nullity." Duke Law professor Joseph Blocher, a leading voice in gun rights scholarship, argued that the majority had misread founding-era history. "Colonial governments absolutely regulated based on status," Blocher wrote in a *New York Times* op-ed. "They disarmed Loyalists, Catholics, and free Blacks without individualized findings of dangerousness. The Founders understood that certain classes posed elevated risks." Blocher predicted that the ruling would lead to challenges against other status-based prohibitions, including the ban on firearm possession by undocumented immigrants under § 922(g)(5). Law enforcement groups expressed concern about officer safety. The National Sheriffs' Association issued a statement saying the decision "ties the hands of deputies who encounter armed individuals under the influence of drugs." The statement noted that 18 officers were killed in cannabis-related incidents between 2020 and 2025, though it did not specify whether the suspects were impaired at the time. The Fraternal Order of Police called on Congress to enact a narrower statute prohibiting gun possession while actually impaired, similar to DUI laws. Public health researchers emphasized that the ruling did not address impaired carry. Dr. Ryan Vandrey, a Johns Hopkins cannabis researcher, said that while regular cannabis users may not pose elevated risks when sober, acute intoxication impairs reaction time and judgment. "The question isn't whether cannabis users should have guns at home," Vandrey said. "It's whether someone who consumed an edible an hour ago should carry a loaded firearm in public. *Danielson* doesn't answer that." Several states, including Colorado and Washington, began drafting "impaired carry" statutes modeled on DUI laws in response. Cannabis industry advocates celebrated the decision as a civil rights victory. NORML Political Director Morgan Fox said the ruling "ends a cruel choice between medicine and self-defense that disproportionately harmed veterans, people of color, and rural Americans." The National Cannabis Industry Association projected that the decision would add 50,000 jobs to the sector by 2027 as security and cultivation roles became accessible to gun owners.

What's Next

The *Danielson* decision triggers immediate regulatory changes and sets the stage for further litigation over related prohibitions.

ATF Form 4473 Revision

The ATF must revise Form 4473 to remove or modify Question 11e, which currently asks about unlawful drug use. The agency announced in July 2026 that it would issue a notice of proposed rulemaking by September 2026, with a final rule expected in early 2027. Industry observers anticipate that the revised form will ask only about substances other than cannabis, or will ask about current impairment rather than status as a user. Gun rights groups have called for complete elimination of drug-related questions, arguing that *Danielson*'s logic extends to all substances.

Pending Prosecutions

The DOJ identified approximately 1,800 pending federal cases involving § 922(g)(3) charges as of June 2026. Of these, roughly 600 involved only cannabis. The department announced it would move to dismiss those cases and would not oppose sentence reductions for individuals already serving time. However, cases involving other controlled substances or additional criminal conduct would proceed. Defense attorneys filed hundreds of post-conviction relief motions in July and August 2026, arguing that *Danielson* required resentencing even where cannabis was not the sole drug involved.

State Permit Systems

States with discretionary concealed carry permitting face pressure to revise standards that exclude cannabis users. The Second Amendment Foundation announced in August 2026 that it would file lawsuits in New York, New Jersey, Maryland, and Hawaii challenging permit denials based on cannabis use. New York City's continued scrutiny of cannabis users prompted a lawsuit filed in the Southern District of New York in September 2026, alleging that the city's policy violated both *Danielson* and the Second Amendment. Constitutional carry states—which allow permitless concealed carry—face fewer immediate changes, though prosecutors in Texas, Tennessee, and Missouri have historically charged cannabis users under state prohibited-person statutes. The Texas Attorney General issued an opinion in August 2026 stating that medical cannabis patients cannot be prosecuted under state gun laws absent evidence of impairment.

Challenges to Other § 922(g) Prohibitions

Legal scholars predict that *Danielson* will fuel challenges to other status-based prohibitions. Section 922(g)(5) prohibits gun possession by undocumented immigrants, a provision that the Fifth Circuit struck down in *United States v. Perez-Gallan* (5th Cir. 2025) before the Supreme Court vacated and remanded for reconsideration in light of *Danielson*. Section 922(g)(8) prohibits possession by persons subject to domestic violence restraining orders, a provision upheld by the Fifth Circuit in *United States v. Rahimi* (5th Cir. 2023) but currently on appeal to the Supreme Court. Gun control advocates worry that *Danielson*'s emphasis on founding-era analogues will undermine modern protective orders and other preventive measures. Everytown for Gun Safety warned in a July 2026 report that the decision "opens the door to dismantling the entire prohibited-person framework that has kept guns out of dangerous hands for 50 years."

Federal Rescheduling and Legislative Response

The DEA's ongoing rescheduling review, initiated in 2022, gained urgency after *Danielson*. The agency published a notice of proposed rulemaking in May 2026 proposing to move cannabis to Schedule III, which would preserve medical use while maintaining some federal controls. The comment period closed in August 2026, with a final rule expected in late 2026 or early 2027. Rescheduling to Schedule III would not directly affect *Danielson*'s holding, since the decision rested on Second Amendment grounds rather than cannabis's schedule, but it would eliminate the statutory basis for calling cannabis use "unlawful." Congressional Republicans introduced the Second Amendment Cannabis Clarification Act in July 2026, which would explicitly exempt state-legal cannabis users from all federal firearm prohibitions. The bill attracted 45 cosponsors, including 12 Democrats, but faced opposition from gun control groups and uncertain prospects in a divided Congress. Senate Judiciary Committee Chairman Dick Durbin said he would hold hearings on the bill in fall 2026 but expressed concern about "creating a carveout that could extend to other drugs."

Further Reading

• Supreme Court opinion: Danielson v. Garland, No. 24-1087 (U.S. June 24, 2026), available at https://www.supremecourt.gov/opinions/25pdf/24-1087_new.pdf
• Gun Control Act of 1968, Pub. L. No. 90-618, 82 Stat. 1213 (codified at 18 U.S.C. §§ 921-931)
• Controlled Substances Act, 21 U.S.C. §§ 801-904
• ATF Open Letter to Federal Firearms Licensees (Sept. 21, 2011), https://www.atf.gov/file/60211/download